Stopping long-term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg-negative chronic hepatitis B.
| Image |  |
|---|---|
| Description | scientific article published in February 2018 |
| Author/s |
author: Florian van Bömmel |
| Publication date | February 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |